The abstract is read at the publisher; the summary is JClub's.
Neural respiratory drive is established as a mechanistic contributor to exertional breathlessness in chronic disease, with neuroimaging supporting a dynamic brain network integrating peripheral and central processes.
- Why it matters: Breathlessness affects an estimated 40% of adults with chronic disease and has major consequences for individuals, carers, and health-care systems, motivating updated mechanisms, measurement, and management guidance.
- What they did: The Dyspnoea Society Research Statement synthesizes recent advances, including neuroimaging of sensorimotor and cognitive-affective regions and improved responsive multidimensional instruments that quantify symptom abnormality relative to physical activity.
- The result: Early low-risk non-pharmacological interventions are supported, pharmacological evidence is limited in most situations, and symptom-focused diagnostic pathways and integrated, disease-agnostic services may improve outcomes while reducing health-care costs.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.